Results 171 to 180 of about 67,701 (309)

Development of a High‐Throughput Microarray Platform for Rapid, Low‐Cost Expanded Carrier Screening

open access: yesPrenatal Diagnosis, EarlyView.
ABSTRACT Objective To develop a customized expanded carrier screening (ECS) solution for 8271 variants of 265 genes. Based on a microarray platform, this solution demonstrates comparable accuracy to next‐generation sequencing (NGS) platform; however, it has a lower cost, a faster speed, and a simplified data—analysis process.
Jiazhen Chang   +11 more
wiley   +1 more source

Soil-derived microbiota induces T regulatory cells and protect against mouse colitis, metabolic disease, and sepsis. [PDF]

open access: yesGut Microbes
Szurek EA   +12 more
europepmc   +1 more source

Novel and High‐Throughput Method of Isolating Single Fetal Cells Using FACS for NIPT

open access: yesPrenatal Diagnosis, EarlyView.
ABSTRACT Objective To evaluate fluorescence activated cell sorting (FACS) as a method of single‐cell isolation of rare circulating fetal cells from maternal blood for use in cell‐based non‐invasive prenatal testing (cbNIPT). Method Blood samples (30 mL) were collected from 75 ‘low‐risk’ pregnant women (gestational age 10–15 weeks).
Ripudaman Singh   +9 more
wiley   +1 more source

Adipocytes influence choroidal neovascularization via PRDM16. [PDF]

open access: yesEMBO Mol Med
Diaz-Marin R   +6 more
europepmc   +1 more source

Molecular and genomic advances in breast cancer: A comprehensive review of predictive and therapeutic innovations

open access: yesPrecision Medical Sciences, EarlyView.
Breast cancer subtypes, estrogen receptor‐positive (ER+), HER2‐enriched, and TNBC, are defined by genomic and epigenetic signatures. Multi‐omics profiling, immunotherapy, liquid biopsy, and AI‐driven radiogenomics enable precision medicine. Tools like Oncotype DX and PAM50 support personalized care.
Samina Malik   +4 more
wiley   +1 more source

CNV-Hub: an integrated web-based platform for CNV classification and interpretation using multi-algorithm consensus. [PDF]

open access: yesNAR Genom Bioinform
Pillay VGV   +14 more
europepmc   +1 more source

Human Blood‐Brain Tumor Barrier on a Chip to Investigate Personalized Treatment for Glioblastoma Patients

open access: yesSmall, EarlyView.
A microfluidic model of the glioblastoma (GBM) margin was developed to mimic patient‐specific blood‐brain tumor barrier (BBTB) function and drug response. The platform revealed inter‐patient variability in barrier integrity and drug sensitivity, offering a tool for personalized therapy evaluation in GBM.
Minsu Ryoo   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy